Breaking Down Biologic Therapies in Moderate to Severe Atopic Dermatitis: Who, What, When, Why, and How?

Deepen your understanding of biologic therapies for treating moderate to severe atopic dermatitis through a webcast, slides, and multiple clinical perspectives.

Share

Program Content

Activities

Biologic Therapies in Moderate to Severe Atopic Dermatitis
The Impact of Emerging Biologic Therapies on Managing Moderate to Severe Atopic Dermatitis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2024

Expires: September 24, 2025

Integrating PROs in AD
Integrating Patient-Reported Outcomes in AD: Personalizing Care and Overcoming Barriers to Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 27, 2024

Expires: September 26, 2025

Faculty

cover img faculity

Sandri Johnson, MSN, FNP-BC, DCNP

Dermatology Nurse Practitioner
Midtown Dermatology
Raleigh and Rocky Mount, North Carolina

cover img faculity

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with the Dermatology Education Foundation Dermalorian™ Webinar Series.

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Dermatology Education Foundation Dermalorian™ Webinar Series

ProCE Banner